Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Labarta

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Current Opinion in Obstetrics & Gynecology|April 26, 2021
New concepts and difficulties with progesterone supplementation in the luteal phaseMaría Cerrillo Martínez, Cristina Rodríguez-Varela, Elena Labarta Demur
Fertility and Sterility|January 31, 2016
Regimen of ovarian stimulation affects oocyte and therefore embryo qualityErnesto Bosch, Elena Labarta, Efstratios Kolibianakis, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 23, 2024
A 12-h Difference in Exogenous Progesterone Initiation Does Not Have an Impact on Ongoing Pregnancy Rates in Artificial Cycles, as Long as Luteal Phase Support Starts Five Days Before Blastocyst TransferCristina Rodríguez-Varela, Maria Salvaleda-Mateu, Ernesto Bosch, et al.
JBRA Assisted Reproduction|January 30, 2024
Detecting partial premature ovulation during follicular aspiration compromises the quantity, but not the quality, of the oocytes retrieved in stimulated in vitro fertilization (IVF) cyclesVíctor Hugo Gómez, Cristina Rodríguez-Varela, Elena Labarta, et al.
Reproductive Biomedicine Online|December 15, 2022
Prediction of ovarian response using the automated Elecsys anti-Müllerian hormone assay in gonadotrophin-releasing hormone antagonist cyclesErnesto Bosch, Elena Labarta, Jose Zuzuarregui, et al.
Reproductive Biomedicine Online|March 29, 2024
Corrigendum to 'Prediction of ovarian response using the automated Elecsys anti-Müllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles' [Reproductive BioMedicine Online (2023) 46 2: 295-301]Ernesto Bosch, Elena Labarta, Jose Zuzuarregui, et al.
Fertility and Sterility|May 24, 2025
Corrigendum to "Minimum number of mature oocytes needed to obtain at least one euploid blastocyst according to female age in in vitro fertilization treatment cycles" (Fertil Steril 2024;122:658-66)Cristina Rodríguez-Varela, Juan Manuel Mascarós, Elena Labarta, et al.
Fertility and Sterility|November 12, 2010
Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysisErnesto Bosch, Elena Labarta, Juana Crespo, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2012
Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cyclesElena Labarta, Ernesto Bosch, Pilar Alamá, et al.
Reproductive Biomedicine Online|March 14, 2024
Luteal phase support using micronized vaginal progesterone as pessaries or capsules in artificial cycles: is there any difference?Elena Labarta, Cristina Rodríguez-Varela, Maria Salvaleda-Mateu, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Current Opinion in Obstetrics & Gynecology|April 26, 2021
New concepts and difficulties with progesterone supplementation in the luteal phaseMaría Cerrillo Martínez, Cristina Rodríguez-Varela, Elena Labarta Demur
Fertility and Sterility|January 31, 2016
Regimen of ovarian stimulation affects oocyte and therefore embryo qualityErnesto Bosch, Elena Labarta, Efstratios Kolibianakis, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 23, 2024
A 12-h Difference in Exogenous Progesterone Initiation Does Not Have an Impact on Ongoing Pregnancy Rates in Artificial Cycles, as Long as Luteal Phase Support Starts Five Days Before Blastocyst TransferCristina Rodríguez-Varela, Maria Salvaleda-Mateu, Ernesto Bosch, et al.
JBRA Assisted Reproduction|January 30, 2024
Detecting partial premature ovulation during follicular aspiration compromises the quantity, but not the quality, of the oocytes retrieved in stimulated in vitro fertilization (IVF) cyclesVíctor Hugo Gómez, Cristina Rodríguez-Varela, Elena Labarta, et al.
Reproductive Biomedicine Online|December 15, 2022
Prediction of ovarian response using the automated Elecsys anti-Müllerian hormone assay in gonadotrophin-releasing hormone antagonist cyclesErnesto Bosch, Elena Labarta, Jose Zuzuarregui, et al.
Reproductive Biomedicine Online|March 29, 2024
Corrigendum to 'Prediction of ovarian response using the automated Elecsys anti-Müllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles' [Reproductive BioMedicine Online (2023) 46 2: 295-301]Ernesto Bosch, Elena Labarta, Jose Zuzuarregui, et al.
Fertility and Sterility|May 24, 2025
Corrigendum to "Minimum number of mature oocytes needed to obtain at least one euploid blastocyst according to female age in in vitro fertilization treatment cycles" (Fertil Steril 2024;122:658-66)Cristina Rodríguez-Varela, Juan Manuel Mascarós, Elena Labarta, et al.
Fertility and Sterility|November 12, 2010
Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysisErnesto Bosch, Elena Labarta, Juana Crespo, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2012
Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cyclesElena Labarta, Ernesto Bosch, Pilar Alamá, et al.
Reproductive Biomedicine Online|March 14, 2024
Luteal phase support using micronized vaginal progesterone as pessaries or capsules in artificial cycles: is there any difference?Elena Labarta, Cristina Rodríguez-Varela, Maria Salvaleda-Mateu, et al.
Pageof 7